NLRC5 and central nervous system cancer: Accumulating reports suggested that deregulation of Wnt/β‐catenin signalling pathway is considered as an important marker in various human tumours.23 Nevertheless, whether Wnt/β‐catenin signalling pathway was involved in NLRC5‐induced malignant progression of glioma cells remains elusive.